NTRA Q1 2024 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q1 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$368M+52.1% YoY

Gross Profit

$209M56.7% margin

Operating Income

-$74M-20.2% margin

Net Income

-$68M-18.4% margin

EPS (Diluted)

$-0.56

QoQ Revenue Growth

+18.2%

Cash Flow

Operating Cash Flow

$27M

Free Cash Flow

$7M

Stock-Based Comp.

$64M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$674M

Stockholders' Equity

$794M

Cash & Equivalents

$814M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$368M	$242M	+52.1%
Gross Profit	$209M	$94M	+122.8%
Operating Income	-$74M	-$138M	+46.3%
Net Income	-$68M	-$137M	+50.6%

Revenue Segments

Product

$365M99%

Licensing and other

$3M1%

Geographic Segments

United States

$359M98%

Europe, Middle East, India, Africa

$5M1%

Asia Pacific and Other

$2M0%

Americas, excluding U.S.

$1M0%